{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:14:13Z","timestamp":1789683253808,"version":"4.0.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2022\/45\/N\/NZ6\/04203"],"award-info":[{"award-number":["UMO-2022\/45\/N\/NZ6\/04203"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2018\/30\/E\/NZ1\/00874"],"award-info":[{"award-number":["UMO-2018\/30\/E\/NZ1\/00874"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02744-4","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T13:23:40Z","timestamp":1745846620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inhibition of ALKBH5 demethylase of m6A pathway potentiates HIV-1 reactivation from latency"],"prefix":"10.1186","volume":"22","author":[{"given":"Haider","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Wadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Bendoumou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Maiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Dutilleul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Selberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Nestola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Lalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Avettand-Feno\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coca","family":"Necsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Marcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esko","family":"Kankuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mati","family":"Karelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"De Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Pyrc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander O.","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Van Lint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kula-Pacurar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"2744_CR1","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","volume":"382","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382:1525\u201333.","journal-title":"Lancet"},{"key":"2744_CR2","doi-asserted-by":"publisher","first-page":"e171554","DOI":"10.1172\/JCI171554","volume":"133","author":"NF McMyn","year":"2023","unstructured":"McMyn NF, Varriale J, Fray EJ, Zitzmann C, MacLeod H, Lai J, Singhal A, Moskovljevic M, Garcia MA, Lopez BM, Hariharan V, Rhodehouse K, Lynn K, Tebas P, Mounzer K, Montaner LJ, Benko E, Kovacs C, Hoh R, Simonetti FR, Laird GM, Deeks SG, Ribeiro RM, Perelson AS, Siliciano RF, Siliciano JM. The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy. J Clin Invest. 2023;133:e171554.","journal-title":"J Clin Invest"},{"key":"2744_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nm880","volume":"9","author":"JD Siliciano","year":"2003","unstructured":"Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4\u2009+\u2009T cells. Nat Med. 2003;9:727\u20138.","journal-title":"Nat Med"},{"key":"2744_CR4","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","volume":"278","author":"JK Wong","year":"1997","unstructured":"Wong JK, Hezareh M, G\u00fcnthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD. Recovery of Replication-Competent HIV despite prolonged suppression of plasma viremia. Science. 1997;278:1291\u20135.","journal-title":"Science"},{"key":"2744_CR5","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1007\/s00018-019-03156-8","volume":"76","author":"I Sadowski","year":"2019","unstructured":"Sadowski I, Hashemi FB. Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs. Cell Mol Life Sci. 2019;76:3583\u2013600.","journal-title":"Cell Mol Life Sci"},{"key":"2744_CR6","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.immuni.2018.04.030","volume":"48","author":"S Sengupta","year":"2018","unstructured":"Sengupta S, Siliciano RF. Targeting the latent reservoir for HIV-1. Immunity. 2018;48:872\u201395.","journal-title":"Immunity"},{"key":"2744_CR7","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.3389\/fmicb.2019.03060","volume":"10","author":"A Ait-Ammar","year":"2020","unstructured":"Ait-Ammar A, Kula A, Darcis G, Verdikt R, De Wit S, Gautier V, Mallon PWG, Marcello A, Rohr O, Van Lint C. Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs. Front Microbiol. 2020;10:3060.","journal-title":"Front Microbiol"},{"key":"2744_CR8","doi-asserted-by":"publisher","first-page":"e1007991","DOI":"10.1371\/journal.ppat.1007991","volume":"15","author":"J Grau-Exp\u00f3sito","year":"2019","unstructured":"Grau-Exp\u00f3sito J, Luque-Ballesteros L, Navarro J, Curran A, Burgos J, Ribera E, Torrella A, Planas B, Bad\u00eda R, Martin-Castillo M, Fern\u00e1ndez-Sojo J, Genesc\u00e0 M, Falc\u00f3 V, Buzon MJ. Latency reversal agents affect differently the latent reservoir present in distinct CD4\u2009+\u2009T subpopulations. PLOS Pathog. 2019;15:e1007991.","journal-title":"PLOS Pathog"},{"key":"2744_CR9","doi-asserted-by":"publisher","first-page":"101478","DOI":"10.1016\/j.smim.2021.101478","volume":"51","author":"A Kula-Pacurar","year":"2021","unstructured":"Kula-Pacurar A, Rodari A, Darcis G, Van Lint C. Shocking HIV-1 with Immunomodulatory latency reversing agents. Semin Immunol. 2021;51:101478.","journal-title":"Semin Immunol"},{"key":"2744_CR10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature11286","volume":"487","author":"NM Archin","year":"2012","unstructured":"Archin NM, Liberty AL, Kashuba AD, Choudhary SK, Kuruc JD, Crooks AM, Parker DC, Anderson EM, Kearney MF, Strain MC, Richman DD, Hudgens MG, Bosch RJ, Coffin JM, Eron JJ, Hazuda DJ, Margolis DM. Administration of Vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature. 2012;487:482\u20135.","journal-title":"Nature"},{"key":"2744_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/QAD.0000000000002083","volume":"33","author":"S Moron-Lopez","year":"2019","unstructured":"Moron-Lopez S, Kim P, S\u00f8gaard OS, Tolstrup M, Wong JK, Yukl SA. Characterization of the HIV-1 transcription profile after Romidepsin administration in ART-suppressed individuals. AIDS. 2019;33:425\u201331.","journal-title":"AIDS"},{"key":"2744_CR12","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/S2352-3018(14)70014-1","volume":"1","author":"TA Rasmussen","year":"2014","unstructured":"Rasmussen TA, Tolstrup M, Brinkmann CR, Olesen R, Erikstrup C, Solomon A, Winckelmann A, Palmer S, Dinarello C, Buzon M, Lichterfeld M, Lewin SR, \u00d8stergaard L, S\u00f8gaard OS. Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1\/2, single group, clinical trial. Lancet HIV. 2014;1:e13\u201321.","journal-title":"Lancet HIV"},{"key":"2744_CR13","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1097\/QAD.0000000000001064","volume":"30","author":"C Guti\u00e9rrez","year":"2016","unstructured":"Guti\u00e9rrez C, Serrano-Villar S, Madrid-Elena N, P\u00e9rez-El\u00edas MJ, Mart\u00edn ME, Barbas C, Ruip\u00e9rez J, Mu\u00f1oz E, Mu\u00f1oz-Fern\u00e1ndez MA, Castor T, Moreno S. Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy. AIDS. 2016;30:1385\u201392.","journal-title":"AIDS"},{"key":"2744_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nm.3489","volume":"20","author":"CK Bullen","year":"2014","unstructured":"Bullen CK, Laird GM, Durand CM, Siliciano JD, Siliciano RF. New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. Nat Med. 2014;20:425\u20139.","journal-title":"Nat Med"},{"key":"2744_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41590-023-01741-5","volume":"25","author":"NL Board","year":"2024","unstructured":"Board NL, Yuan Z, Wu F, Moskovljevic M, Ravi M, Sengupta S, Mun SS, Simonetti FR, Lai J, Tebas P, Lynn K, Hoh R, Deeks SG, Siliciano JD, Montaner LJ, Siliciano RF. Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells. Nat Immunol. 2024;25:462\u201370.","journal-title":"Nat Immunol"},{"key":"2744_CR16","doi-asserted-by":"publisher","first-page":"e1005063","DOI":"10.1371\/journal.ppat.1005063","volume":"11","author":"G Darcis","year":"2015","unstructured":"Darcis G, Kula A, Bouchat S, Fujinaga K, Corazza F, Ait-Ammar A, Delacourt N, Melard A, Kabeya K, Vanhulle C, Van Driessche B, Gatot J-S, Cherrier T, Pianowski LF, Gama L, Schwartz C, Vila J, Burny A, Clumeck N, Moutschen M, De Wit S, Peterlin BM, Rouzioux C, Rohr O, Van Lint C. An in-Depth comparison of latency-Reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified Bryostatin-1\u2009+\u2009JQ1 and ingenol-B\u2009+\u2009JQ1 to potently reactivate viral gene expression. PLoS Pathog. 2015;11:e1005063.","journal-title":"PLoS Pathog"},{"key":"2744_CR17","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1172\/JCI80142","volume":"125","author":"GM Laird","year":"2015","unstructured":"Laird GM, Bullen CK, Rosenbloom DIS, Martin AR, Hill AL, Durand CM, Siliciano JD, Siliciano RF. Ex vivo analysis identifies effective HIV-1 latency\u2013reversing drug combinations. J Clin Invest. 2015;125:1901\u201312.","journal-title":"J Clin Invest"},{"key":"2744_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.15252\/emmm.201505557","volume":"8","author":"S Bouchat","year":"2016","unstructured":"Bouchat S, Delacourt N, Kula A, Darcis G, Van Driessche B, Corazza F, Gatot J, Melard A, Vanhulle C, Kabeya K, Pardons M, Avettand-Fenoel V, Clumeck N, De Wit S, Rohr O, Rouzioux C. Lint, C. Sequential treatment with 5\u2010aza\u20102\u2032\u2010deoxycytidine and deacetylase inhibitors reactivates HIV\u20101. EMBO Mol Med. 2016;8:117\u201338. Van.","journal-title":"EMBO Mol Med"},{"key":"2744_CR19","doi-asserted-by":"publisher","first-page":"e1004156","DOI":"10.1371\/journal.ppat.1004156","volume":"10","author":"P Mohammadi","year":"2014","unstructured":"Mohammadi P, di Iulio J, Mu\u00f1oz M, Martinez R, Bartha I, Cavassini M, Thorball C, Fellay J, Beerenwinkel N, Ciuffi A, Telenti A. Dynamics of HIV latency and reactivation in a primary CD4\u2009+\u2009T cell model. PLoS Pathog. 2014;10:e1004156.","journal-title":"PLoS Pathog"},{"key":"2744_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jve.2024.100450","volume":"10","author":"A Dorman","year":"2024","unstructured":"Dorman A, Bendoumou M, Valaitiene A, Wadas J, Ali H, Dutilleul A, Maiuri P, Nestola L, Bociaga-Jasik M, Mchantaf G, Avettand-Feno\u00ebl V, Marcello A, Pyrc K, Pasternak AO, Lint CV. Kula-Pacurar, A. PP1.1\u201300164 nuclear retention of unspliced HIV-1 RNA as a novel reversible posttranscriptional block in latency. J Virus Erad. 2024;10:39.","journal-title":"J Virus Erad"},{"key":"2744_CR21","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2744_CR22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/cac2.12161","volume":"41","author":"S Dong","year":"2021","unstructured":"Dong S, Wu Y, Liu Y, Weng H, Huang H. N6 -methyladenosine steers RNA metabolism and regulation in Cancer. Cancer Commun Lond Engl. 2021;41:538\u201359.","journal-title":"Cancer Commun Lond Engl"},{"key":"2744_CR23","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C. Where, when, and how: Context-Dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74:640\u201350.","journal-title":"Mol Cell"},{"key":"2744_CR24","doi-asserted-by":"crossref","unstructured":"Luo Q, Gao Y, Zhang L, Rao J, Guo Y, Huang Z, Li J, Decreased. ALKBH5, FTO, and YTHDF2 in Peripheral Blood Are as Risk Factors for Rheumatoid Arthritis. BioMed Res. Int. 2020, 5735279 (2020).","DOI":"10.1155\/2020\/5735279"},{"key":"2744_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13045-022-01224-4","volume":"15","author":"J Qu","year":"2022","unstructured":"Qu J, Yan H, Hou Y, Cao W, Liu Y, Zhang E, He J, Cai. Z. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential. J Hematol Oncol J Hematol Oncol. 2022;15:8.","journal-title":"J Hematol Oncol J Hematol Oncol"},{"key":"2744_CR26","doi-asserted-by":"publisher","first-page":"849592","DOI":"10.3389\/fimmu.2022.849592","volume":"13","author":"C Wei","year":"2022","unstructured":"Wei C, Wang B, Peng D, Zhang X, Li Z, Luo L, He Y, Liang H, Du X, Li S, Zhang S, Zhang Z, Han L, Zhang J. Pan-Cancer analysis shows that ALKBH5 is a potential prognostic and immunotherapeutic biomarker for multiple Cancer types including gliomas. Front Immunol. 2022;13:849592.","journal-title":"Front Immunol"},{"key":"2744_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, Yang C, Chen Y. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.","journal-title":"Signal Transduct Target Ther"},{"key":"2744_CR28","doi-asserted-by":"publisher","first-page":"16011","DOI":"10.1038\/nmicrobiol.2016.11","volume":"1","author":"G Lichinchi","year":"2016","unstructured":"Lichinchi G, Gao S, Saletore Y, Gonzalez GM, Bansal V, Wang Y, Mason CE, Rana TM. Dynamics of the human and viral m(6)A RNA methylomes during HIV-1 infection of T cells. Nat Microbiol. 2016;1:16011.","journal-title":"Nat Microbiol"},{"key":"2744_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.chom.2016.04.002","volume":"19","author":"EM Kennedy","year":"2016","unstructured":"Kennedy EM, Bogerd HP, Kornepati AVR, Kang D, Ghoshal D, Marshall JB, Poling BC, Tsai K, Gokhale NS, Horner SM, Cullen BR. Posttranscriptional m(6)A editing of HIV-1 mRNAs enhances viral gene expression. Cell Host Microbe. 2016;19:675\u201385.","journal-title":"Cell Host Microbe"},{"key":"2744_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fviro.2021.714475","volume":"1","author":"S Cristinelli","year":"2021","unstructured":"Cristinelli S, Angelino P, Janowczyk A, Delorenzi M, Ciuffi. A. HIV modifies the m6A and m5C epitranscriptomic landscape of the host cell. Front Virol. 2021;1:11.","journal-title":"Front Virol"},{"key":"2744_CR31","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1101\/gad.348508.121","volume":"35","author":"K Tsai","year":"2021","unstructured":"Tsai K, Bogerd HP, Kennedy EM, Emery A, Swanstrom R, Cullen BR. Epitranscriptomic addition of m 6 A regulates HIV-1 RNA stability and alternative splicing. Genes Dev. 2021;35:992\u20131004.","journal-title":"Genes Dev"},{"key":"2744_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12977-022-00589-1","volume":"19","author":"S N\u2019Da Konan","year":"2022","unstructured":"N\u2019Da Konan S, S\u00e9g\u00e9ral E, Bejjani F, Bendoumou M, Ait Said M, Gallois-Montbrun S, Emiliani S. YTHDC1 regulates distinct post-integration steps of HIV-1 replication and is important for viral infectivity. Retrovirology. 2022;19:4.","journal-title":"Retrovirology"},{"key":"2744_CR33","doi-asserted-by":"publisher","first-page":"e15528","DOI":"10.7554\/eLife.15528","volume":"5","author":"N Tirumuru","year":"2016","unstructured":"Tirumuru N, Zhao BS, Lu W, Lu Z, He C, Wu L. N6-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 gag protein expression. eLife. 2016;5:e15528.","journal-title":"eLife"},{"key":"2744_CR34","doi-asserted-by":"publisher","first-page":"12992","DOI":"10.1074\/jbc.RA118.004215","volume":"293","author":"W Lu","year":"2018","unstructured":"Lu W, Tirumuru N, Gelais S, Koneru C, Liu PC, Kvaratskhelia C, He M, C., Wu L. N6-Methyladenosine-binding proteins suppress HIV-1 infectivity and viral production. J Biol Chem. 2018;293:12992\u20133005.","journal-title":"J Biol Chem"},{"key":"2744_CR35","doi-asserted-by":"publisher","first-page":"e1008305","DOI":"10.1371\/journal.ppat.1008305","volume":"16","author":"D Jurczyszak","year":"2020","unstructured":"Jurczyszak D, Zhang W, Terry SN, Kehrer T, Berm\u00fadez Gonz\u00e1lez MC, McGregor E, Mulder LCF, Eckwahl MJ, Pan T. Simon, V. HIV protease cleaves the antiviral m6A reader protein YTHDF3 in the viral particle. PLoS Pathog. 2020;16:e1008305.","journal-title":"PLoS Pathog"},{"key":"2744_CR36","doi-asserted-by":"publisher","first-page":"15957","DOI":"10.1021\/acsomega.1c01626","volume":"6","author":"S Selberg","year":"2021","unstructured":"Selberg S, \u017dusinaite E, Herodes K, Seli N, Kankuri E, Merits A, Karelson M. HIV replication is increased by RNA methylation METTL3\/METTL14\/WTAP complex activators. ACS Omega. 2021;6:15957\u201363.","journal-title":"ACS Omega"},{"key":"2744_CR37","doi-asserted-by":"publisher","first-page":"13310","DOI":"10.1021\/acsomega.1c01289","volume":"6","author":"S Selberg","year":"2021","unstructured":"Selberg S, Seli N, Kankuri E, Karelson M. Rational design of novel anticancer Small-Molecule RNA m6A demethylase ALKBH5 inhibitors. ACS Omega. 2021;6:13310\u201320.","journal-title":"ACS Omega"},{"key":"2744_CR38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, Pilka ES, Aspris D, Leggate D, Hendrick AG, Webster NA, Andrews B, Fosbeary R, Guest P, Irigoyen N, Eleftheriou M, Gozdecka M, Dias JML, Bannister AJ, Vick B, Jeremias I, Vassiliou GS, Rausch O, Tzelepis K, Kouzarides T. Small-molecule Inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597\u2013601.","journal-title":"Nature"},{"key":"2744_CR39","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1111\/odi.14864","volume":"30","author":"L Liu","year":"2024","unstructured":"Liu L, Zhao T, Zheng S, Tang D, Han H, Yang C, Zheng X, Wang J, Ma J, Wei W, Wang Z, He S, He Q. METTL3 inhibitor STM2457 impairs tumor progression and enhances sensitivity to anlotinib in OSCC. Oral Dis. 2024;30:4243\u201354.","journal-title":"Oral Dis"},{"key":"2744_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0959-8049(22)01128-5","volume":"174","author":"Y Ofir-Rosenfeld","year":"2022","unstructured":"Ofir-Rosenfeld Y, Vasiliauskait\u0117 L, Saunders C, Sapetschnig A, Tsagkogeorga G, Albertella M, Carkill M, Self-Fordham J, Holz JB, Rausch O. STC-15, an oral small molecule inhibitor of the RNA methyltransferase METTL3, inhibits tumour growth through activation of anti-cancer immune responses associated with increased interferon signalling, and synergises with T cell checkpoint Blockade. Eur J Cancer. 2022;174:123.","journal-title":"Eur J Cancer"},{"key":"2744_CR41","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/0042-6822(78)90191-5","volume":"89","author":"JP Bader","year":"1978","unstructured":"Bader JP, Brown NR, Chiang PK, Cantoni GL. 3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells. Virology. 1978;89:494\u2013505.","journal-title":"Virology"},{"key":"2744_CR42","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/0042-6822(90)90517-U","volume":"177","author":"AAH Fischer","year":"1990","unstructured":"Fischer AAH, M\u00fcller K, Scholtissek C. Specific Inhibition of the synthesis of influenza virus late proteins and stimulation of early, M2, and NS2 protein synthesis by 3-deazaadenosine. Virology. 1990;177:523\u201331.","journal-title":"Virology"},{"key":"2744_CR43","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/0140-6736(92)90133-N","volume":"339","author":"CW Flexner","year":"1992","unstructured":"Flexner CW, Hildreth JE, Kuncl RW, Drachman. DanielB. 3-deaza-adenosine and Inhibition of HIV. Lancet. 1992;339:438.","journal-title":"Lancet"},{"key":"2744_CR44","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1016\/j.celrep.2019.02.100","volume":"26","author":"S Selberg","year":"2019","unstructured":"Selberg S, Blokhina D, Aatonen M, Koivisto P, Siltanen A, Mervaala E, Kankuri E, Karelson M. Discovery of small molecules that activate RNA methylation through cooperative binding to the METTL3-14-WTAP complex active site. Cell Rep. 2019;26:3762\u2013e37715.","journal-title":"Cell Rep"},{"key":"2744_CR45","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","volume":"22","author":"A Jordan","year":"2003","unstructured":"Jordan A. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 2003;22:1868\u201377.","journal-title":"EMBO J"},{"key":"2744_CR46","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1126\/science.3313729","volume":"238","author":"TM Folks","year":"1987","unstructured":"Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokine-Induced expression of HIV-1 in a chronically infected promonocyte cell line. Science. 1987;238:800\u20132.","journal-title":"Science"},{"key":"2744_CR47","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/s41467-025-57290-y","volume":"16","author":"A Dorman","year":"2025","unstructured":"Dorman A, Bendoumou M, Valaitien\u0117 A, Wadas J, Ali H, Dutilleul A, Maiuri P, Nestola L, Bociaga-Jasik M, Mchantaf G, Necsoi C, De Wit S, Avettand-Feno\u00ebl V, Marcello A, Pyrc K, Pasternak AO, Van Lint C. Kula-Pacurar, A. Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency. Nat Commun. 2025;16:2078.","journal-title":"Nat Commun"},{"key":"2744_CR48","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1083\/jcb.201004104","volume":"189","author":"M Linkert","year":"2010","unstructured":"Linkert M, Rueden CT, Allan C, Burel J-M, Moore W, Patterson A, Loranger B, Moore J, Neves C, MacDonald D, Tarkowska A, Sticco C, Hill E, Rossner M, Eliceiri KW, Swedlow JR. Metadata matters: access to image data in the real world. J Cell Biol. 2010;189:777\u201382.","journal-title":"J Cell Biol"},{"key":"2744_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","volume":"224","author":"S Bolte","year":"2006","unstructured":"Bolte S, Cordeli\u00e8res FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006;224:213\u201332.","journal-title":"J Microsc"},{"key":"2744_CR50","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.3390\/ijms22094537","volume":"22","author":"S Selberg","year":"2021","unstructured":"Selberg S, Yu L-Y, Bondarenko O, Kankuri E, Seli N, Kovaleva V, Herodes K, Saarma M, Karelson M. Small-Molecule inhibitors of the RNA M6A demethylases FTO potently support the survival of dopamine neurons. Int J Mol Sci. 2021;22:4537.","journal-title":"Int J Mol Sci"},{"key":"2744_CR51","doi-asserted-by":"publisher","first-page":"eaap9927","DOI":"10.1126\/scitranslmed.aap9927","volume":"10","author":"SA Yukl","year":"2018","unstructured":"Yukl SA, Kaiser P, Kim P, Telwatte S, Joshi SK, Vu M, Lampiris H, Wong J. K. HIV latency in isolated patient CD4\u2009+\u2009T cells May be due to blocks in HIV transcriptional elongation, completion, and splicing. Sci Transl Med. 2018;10:eaap9927.","journal-title":"Sci Transl Med"},{"key":"2744_CR52","doi-asserted-by":"publisher","first-page":"e1007357","DOI":"10.1371\/journal.ppat.1007357","volume":"14","author":"S Telwatte","year":"2018","unstructured":"Telwatte S, Lee S, Somsouk M, Hatano H, Baker C, Kaiser P, Kim P, Chen T-H, Milush J, Hunt PW, Deeks SG, Wong JK, Yukl SA. Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency. PLoS Pathog. 2018;14:e1007357.","journal-title":"PLoS Pathog"},{"key":"2744_CR53","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1371\/journal.ppat.0020068","volume":"2","author":"KG Lassen","year":"2006","unstructured":"Lassen KG, Ramyar KX, Bailey JR, Zhou Y, Siliciano RF. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4\u2009+\u2009T cells. PLoS Pathog. 2006;2:e68.","journal-title":"PLoS Pathog"},{"key":"2744_CR54","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1517\/13543784.2011.594437","volume":"20","author":"EM Bertino","year":"2011","unstructured":"Bertino EM, Otterson GA. Romidepsin: a novel histone deacetylase inhibitor for cancer. Expert Opin Investig Drugs. 2011;20:1151\u20138.","journal-title":"Expert Opin Investig Drugs"},{"key":"2744_CR55","doi-asserted-by":"publisher","first-page":"e1004071","DOI":"10.1371\/journal.ppat.1004071","volume":"10","author":"DG Wei","year":"2014","unstructured":"Wei DG, Chiang V, Fyne E, Balakrishnan M, Barnes T, Graupe M, Hesselgesser J, Irrinki A, Murry JP, Stepan G, Stray KM, Tsai A, Yu H, Spindler J, Kearney M, Spina CA, McMahon D, Lalezari J, Sloan D, Mellors J, Geleziunas R, Cihlar T. Histone deacetylase inhibitor Romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing. PLoS Pathog. 2014;10:e1004071.","journal-title":"PLoS Pathog"},{"key":"2744_CR56","doi-asserted-by":"publisher","first-page":"e1005142","DOI":"10.1371\/journal.ppat.1005142","volume":"11","author":"OS S\u00f8gaard","year":"2015","unstructured":"S\u00f8gaard OS, Graversen ME, Leth S, Olesen R, Brinkmann CR, Nissen SK, Kjaer AS, Schleimann MH, Denton PW, Hey-Cunningham WJ, Koelsch KK, Pantaleo G, Krogsgaard K, Sommerfelt M, Fromentin R, Chomont N, Rasmussen TA, \u00d8stergaard L, Tolstrup M. The depsipeptide Romidepsin reverses HIV-1 latency in vivo. PLOS Pathog. 2015;11:e1005142.","journal-title":"PLOS Pathog"},{"key":"2744_CR57","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1038\/s41591-022-02023-7","volume":"28","author":"JD Gunst","year":"2022","unstructured":"Gunst JD, Pahus MH, Ros\u00e1s-Umbert M, Lu I-N, Benfield T, Nielsen H, Johansen IS, Mohey R, \u00d8stergaard L, Klastrup V, Khan M, Schleimann MH, Olesen R, St\u00f8vring H, Denton PW, Kinloch NN, Copertino DC, Ward AR, Alberto WDC, Nielsen SD, Puertas MC, Ramos V, Reeves JD, Petropoulos CJ, Martinez-Picado J, Brumme ZL, Jones RB, Fox J, Tolstrup M, Nussenzweig MC, Caskey M, Fidler S, S\u00f8gaard OS. Early intervention with 3BNC117 and Romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b\/2a, randomized trial. Nat Med. 2022;28:2424\u201335.","journal-title":"Nat Med"},{"key":"2744_CR58","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/S2352-3018(16)30055-8","volume":"3","author":"S Leth","year":"2016","unstructured":"Leth S, Schleimann MH, Nissen SK, H\u00f8jen JF, Olesen R, Graversen ME, J\u00f8rgensen S, Kj\u00e6r AS, Denton PW, M\u00f8rk A, Sommerfelt MA, Krogsgaard K, \u00d8stergaard L, Rasmussen TA, Tolstrup M, S\u00f8gaard OS. Combined effect of Vacc-4x, Recombinant human granulocyte macrophage colony-stimulating factor vaccination, and Romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B\/2A trial. Lancet HIV. 2016;3:e463\u201372.","journal-title":"Lancet HIV"},{"key":"2744_CR59","doi-asserted-by":"publisher","first-page":"e02214","DOI":"10.1128\/mbio.02214-24","volume":"15","author":"T Mishra","year":"2024","unstructured":"Mishra T, Phillips S, Zhao Y, Wilms B, He C, Wu L. Epitranscriptomic m6 A modifications during reactivation of HIV-1 latency in CD4+ T cells. mBio. 2024;15:e02214\u201324.","journal-title":"mBio"},{"key":"2744_CR60","doi-asserted-by":"publisher","unstructured":"Zhao M, De Crignis E, Rokx C, Verbon A, Gelder TV, Mahmoudi T, et la. T cell toxicity of HIV latency reversing agents. Pharmacol Res 2019;139:524\u201334. https:\/\/doi.org\/10.1016\/j.phrs.2018.10.023","DOI":"10.1016\/j.phrs.2018.10.023"},{"key":"2744_CR61","doi-asserted-by":"publisher","unstructured":"Deng Q, Guo T, Qiu Z, Chen Y. Modeling the cytotoxicity of Romidepsin reveals the ineffectiveness of this drug in the \u201cshock and kill\u201d strategy 2023;173:113702. https:\/\/doi.org\/10.1016\/j.chaos.2023.113702","DOI":"10.1016\/j.chaos.2023.113702"},{"key":"2744_CR62","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/QAI.0000000000001958","volume":"80","author":"A Kula","year":"2019","unstructured":"Kula A, Delacourt N, Bouchat S, Darcis G, Avettand-Fenoel V, Verdikt R, Corazza F, Necsoi C, Vanhulle C, Bendoumou M, Burny A, De Wit S, Rouzioux C, Rohr O, Van Lint C. Heterogeneous HIV-1 reactivation patterns of Disulfiram and combined Disulfiram\u2009+\u2009Romidepsin treatments. J Acquir Immune Defic Syndr 1999. 2019;80:605\u201313.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"2744_CR63","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.molcel.2021.12.038","volume":"82","author":"M Tegowski","year":"2022","unstructured":"Tegowski M, Flamand MN, Meyer K. D. scDART-seq reveals distinct m6A signatures and mRNA methylation heterogeneity in single cells. Mol Cell. 2022;82:868\u2013e87810.","journal-title":"Mol Cell"},{"key":"2744_CR64","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1093\/nar\/gky029","volume":"46","author":"W McIntyre","year":"2018","unstructured":"McIntyre W, Netzband R, Bonenfant G, Biegel JM, Miller C, Fuchs G, Henderson E, Arra M, Canki M, Fabris D, Pager CT. Positive-sense RNA viruses reveal the complexity and dynamics of the cellular and viral epitranscriptomes during infection. Nucleic Acids Res. 2018;46:5776\u201391.","journal-title":"Nucleic Acids Res"},{"key":"2744_CR65","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1093\/nar\/gkac062","volume":"50","author":"C Pereira-Montecinos","year":"2022","unstructured":"Pereira-Montecinos C, Toro-Ascuy D, Anan\u00edas-S\u00e1ez C, Gaete-Argel A, Rojas-Fuentes C, Riquelme-Barrios S, Rojas-Araya B, Garc\u00eda-de-Gracia F, Aguilera-Cort\u00e9s P, Chnaiderman J, Acevedo ML, Valiente-Echeverr\u00eda F, Soto-Rifo R. Epitranscriptomic regulation of HIV-1 full-length RNA packaging. Nucleic Acids Res. 2022;50:2302\u201318.","journal-title":"Nucleic Acids Res"},{"key":"2744_CR66","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.chom.2019.07.005","volume":"26","author":"DG Courtney","year":"2019","unstructured":"Courtney DG, Tsai K, Bogerd HP, Kennedy EM, Law BA, Emery A, Swanstrom R, Holley CL, Cullen BR. Epitranscriptomic addition of m5C to HIV-1 transcripts regulates viral gene expression. Cell Host Microbe. 2019;26:217\u2013e2276.","journal-title":"Cell Host Microbe"},{"key":"2744_CR67","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/s41564-024-01638-5","volume":"9","author":"A Baek","year":"2024","unstructured":"Baek A, Lee G-E, Golconda S, Rayhan A, Manganaris AA, Chen S, Tirumuru N, Yu H, Kim S, Kimmel C, Zablocki O, Sullivan MB, Addepalli B, Wu L, Kim S. Single-molecule epitranscriptomic analysis of full-length HIV-1 RNAs reveals functional roles of site-specific m6As. Nat Microbiol. 2024;9:1340\u201355.","journal-title":"Nat Microbiol"},{"key":"2744_CR68","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G, Ren B, Pan T, He C. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117\u201320.","journal-title":"Nature"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02744-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T14:03:31Z","timestamp":1745849011000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02744-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02744-4","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was granted by the Human Subject Ethics Committees of the Saint-Pierre Hospital (Brussels, Belgium). All individuals enrolled in the study provided written informed consent for donating blood.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.O.P. received a research grant from Gilead Sciences Research Program. C.V.L. received a research grant from ViiV Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}